APA

Stutterheim J., Ichou F. A., den Ouden E., Versteeg R., Caron H. N., Tytgat G. A. M. & van der Schoot C. E. (20120524). Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Stutterheim Janine, Ichou Fatima Ait, den Ouden Emmy, Versteeg Rogier, Caron Huib N, Tytgat Godelieve A M and van der Schoot C Ellen. 20120524. Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Stutterheim J., Ichou F. A., den Ouden E., Versteeg R., Caron H. N., Tytgat G. A. M. and van der Schoot C. E. (20120524). Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Stutterheim Janine, Ichou Fatima Ait, den Ouden Emmy, Versteeg Rogier, Caron Huib N, Tytgat Godelieve A M and van der Schoot C Ellen. Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20120524.